Marsh & McLennan Companies (NYSE:MRSH) Price Target Raised to $197.00 at Mizuho

Marsh & McLennan Companies (NYSE:MRSHFree Report) had its target price upped by Mizuho from $194.00 to $197.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has a neutral rating on the financial services provider’s stock.

MRSH has been the subject of several other research reports. Wells Fargo & Company dropped their price objective on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a report on Thursday, April 9th. Piper Sandler decreased their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Barclays dropped their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. JPMorgan Chase & Co. reduced their price objective on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a research note on Thursday, April 9th. Finally, Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective on the stock in a report on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Marsh & McLennan Companies has a consensus rating of “Hold” and a consensus price target of $200.44.

Get Our Latest Stock Report on MRSH

Marsh & McLennan Companies Trading Down 0.1%

Marsh & McLennan Companies stock opened at $178.81 on Thursday. Marsh & McLennan Companies has a 1 year low of $156.60 and a 1 year high of $216.32. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. The company has a market cap of $86.38 billion, a PE ratio of 22.35, a P/E/G ratio of 2.61 and a beta of 0.61.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last issued its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. The firm had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, equities analysts forecast that Marsh & McLennan Companies will post 10.37 EPS for the current year.

Marsh & McLennan Companies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Thursday, July 23rd will be given a dividend of $0.99 per share. This represents a $3.96 dividend on an annualized basis and a yield of 2.2%. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date is Thursday, July 23rd. Marsh & McLennan Companies’s dividend payout ratio (DPR) is currently 45.00%.

Insider Activity

In other news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the transaction, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by insiders.

Institutional Trading of Marsh & McLennan Companies

A number of institutional investors have recently bought and sold shares of MRSH. Numerai GP LLC increased its position in Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after buying an additional 33,729 shares during the last quarter. Swiss Life Asset Management Ltd lifted its position in shares of Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after buying an additional 11,648 shares during the last quarter. Sarasin & Partners LLP boosted its stake in shares of Marsh & McLennan Companies by 0.9% during the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after acquiring an additional 8,283 shares during the period. CSM Advisors LLC acquired a new position in shares of Marsh & McLennan Companies during the 3rd quarter worth approximately $1,180,000. Finally, Brown Brothers Harriman & Co. increased its holdings in shares of Marsh & McLennan Companies by 26.4% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider’s stock worth $27,444,000 after acquiring an additional 28,419 shares during the last quarter. 87.99% of the stock is currently owned by institutional investors.

More Marsh & McLennan Companies News

Here are the key news stories impacting Marsh & McLennan Companies this week:

About Marsh & McLennan Companies

(Get Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Featured Stories

Analyst Recommendations for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.